Melstrom, Laleh
Chen, Jianjun http://orcid.org/0000-0003-3749-2902
Funding for this research was provided by:
City of Hope
U.S. Department of Health & Human Services | National Institutes of Health (R01 CA214965, R01 CA236399)
U.S. Department of Health & Human Services | National Institutes of Health
DH | NIHR | Invention for Innovation Programme (R01 CA211614)
Article History
Received: 8 August 2019
Revised: 20 November 2019
Accepted: 7 January 2020
First Online: 20 January 2020
Compliance with ethical standards
:
: JC has a patent filed based on his R-2HG/FTO work. JC is a scientific founder and the chief scientific officer of Genovel Biotech Corp. and also holds equity with this company.